A laboratorija - Company finances
|
EUR
|
2021
From: 2021-01-11
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 37,586 | 45,336 | 40,599 | 42,700 | 51,716 |
| Profit before tax | 11,914 | 6,062 | 661 | -6,352 | -3,838 |
| Net profit | 11,318 | 5,753 | 628 | -6,352 | -3,838 |
| Equity | 11,318 | 17,071 | 17,699 | 11,347 | 5,789 |
| Liabilities | - | 4,485 | 3,435 | 0 | 1,244 |
| Non-current assets | 470 | 336 | 571 | 336 | 168 |
| Current assets | 15,187 | 21,220 | 20,563 | 15,293 | 6,865 |
| Total assets | 15,657 | 21,556 | 21,134 | 15,629 | 7,033 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 337 | 36 | - |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +20.6% | -10.4% | +5.2% | +21.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 72.3% | 26.7% | 3.0% | -40.6% | -54.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 33.7% | 3.5% | -56.0% | -66.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 30.1% | 12.7% | 1.5% | -14.9% | -7.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 31.7% | 13.4% | 1.6% | -14.9% | -7.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.3 | 0.2 | - | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
A laboratorija - Social security debts
The amount of overdue SODRA debt for the company A laboratorija as of the last working day is: 80 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 80.48 |
| 2026-09-01 | 2026-09-02 | 80.48 |
| 2026-08-01 | 2026-08-11 | 563.36 |
| 2026-07-01 | 2026-07-31 | 482.88 |
| 2026-06-11 | 2026-06-30 | 402.40 |
| 2026-01-01 | 2026-03-31 | 139.80 |
| 2025-12-02 | 2025-12-31 | 67.35 |
| 2025-10-01 | 2025-10-31 | 72.45 |
| 2025-09-02 | 2025-09-30 | 144.90 |
| 2025-08-01 | 2025-09-01 | 72.45 |
| 2025-07-01 | 2025-07-31 | 144.90 |
| 2025-06-04 | 2025-06-30 | 72.45 |
| 2025-06-03 | 2025-06-03 | 217.35 |
| 2025-05-04 | 2025-06-02 | 144.90 |
| 2025-04-01 | 2025-04-30 | 72.45 |
| 2025-03-04 | 2025-03-31 | 144.90 |
| 2025-03-03 | 2025-03-03 | 72.45 |
| 2025-03-01 | 2025-03-02 | 144.90 |
| 2025-02-01 | 2025-02-28 | 72.45 |
| 2025-01-02 | 2025-01-31 | 129.00 |
| 2024-12-03 | 2024-12-31 | 64.50 |
| 2024-11-04 | 2024-11-30 | 129.00 |
| 2024-10-01 | 2024-11-03 | 64.50 |
| 2024-09-03 | 2024-09-30 | 129.00 |
| 2024-08-01 | 2024-09-02 | 64.50 |
| 2024-07-02 | 2024-07-31 | 1811.27 |
| 2024-06-03 | 2024-07-01 | 1746.77 |
| 2024-05-15 | 2024-06-02 | 1682.27 |
| 2024-05-02 | 2024-05-14 | 1458.22 |
| 2024-04-03 | 2024-05-01 | 1393.72 |
| 2024-03-01 | 2024-04-02 | 1329.22 |
| 2024-02-26 | 2024-02-29 | 1264.72 |
| 2024-02-01 | 2024-02-25 | 1424.27 |
| 2024-01-03 | 2024-01-31 | 1359.77 |
| 2023-12-01 | 2024-01-02 | 1301.14 |
| 2023-11-03 | 2023-11-30 | 1242.51 |
| 2023-10-03 | 2023-11-02 | 1183.88 |
| 2023-09-01 | 2023-10-02 | 1125.25 |
| 2023-08-09 | 2023-08-31 | 1066.62 |
| 2023-07-19 | 2023-07-31 | 1007.99 |
| 2023-01-03 | 2023-01-31 | 656.21 |
| 2022-12-13 | 2023-01-02 | 605.26 |
| 2022-01-03 | 2022-01-31 | 44.81 |
| 2021-11-04 | 2021-12-31 | 44.81 |
| 2021-10-01 | 2021-10-31 | 44.81 |
| 2021-09-01 | 2021-09-30 | 89.62 |
A laboratorija - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company A laboratorija is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2024-06-28 | 2026-09-02 | 0.09 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
A laboratorija, MB (code 305679818) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €51.7K, up 21.1% year on year and 27.4% over two years. Despite the higher turnover, profitability remained negative: net loss was €3.8K, compared with a €6.4K loss in 2024 and a small €628 profit in 2023. The 2025 profit margin was -7.4%, showing an improvement from -14.9% in 2024 but still below break-even. Balance sheet size also contracted over the period, with total assets falling from €21.1K in 2023 to €15.6K in 2024 and €7.0K in 2025. Equity declined from €17.7K to €5.8K, while liabilities were €1.2K in 2025. The equity ratio stood at 82.3%, debt-to-equity at 0.21, and asset turnover at 7.35x, indicating a small, asset-light structure with relatively efficient use of assets in revenue generation.